Clinical Trial Update: Using Gilteritinib to Keep People With Acute Myeloid Leukemia Cancer-free After a Stem Cell Transplant

View source ↗

Summary

This clinical trial update discusses using gilteritinib to help maintain remission in patients with acute myeloid leukemia after stem cell transplantation; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Gilteritinib (gilteritinib)

Snippet

Sponsor: Astellas Pharma Singapore Pte. Ltd. | Conditions: Acute Myeloid Leukemia | Status: COMPLETED